Biology and significance of alpha‐fetoprotein in hepatocellular carcinoma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biology and significance of alpha‐fetoprotein in hepatocellular carcinoma
Authors
Keywords
-
Journal
LIVER INTERNATIONAL
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-08-22
DOI
10.1111/liv.14223
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2019) Andrew X Zhu et al. LANCET ONCOLOGY
- Alpha fetoprotein (AFP) response and efficacy outcomes in the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in advanced hepatocellular carcinoma (HCC).
- (2019) Robin Kate Kelley et al. JOURNAL OF CLINICAL ONCOLOGY
- Subsequent anticancer medication following first-line lenvatinib: A posthoc responder analysis from the phase 3 REFLECT study in unresectable hepatocellular carcinoma.
- (2019) Angel Alsina et al. JOURNAL OF CLINICAL ONCOLOGY
- Biomarkers Associated With Response to Regorafenib in Patients With Hepatocellular Carcinoma
- (2019) Michael Teufel et al. GASTROENTEROLOGY
- TGF-β1 Promotes Hepatocellular Carcinoma Invasion and Metastasis via ERK Pathway-Mediated FGFR4 Expression
- (2018) Jiawei Huang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- The search for biomarkers of hepatocellular carcinoma and the impact on patient outcome
- (2018) Alyson P Black et al. CURRENT OPINION IN PHARMACOLOGY
- Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma
- (2018) Vincenzo Mazzaferro et al. GASTROENTEROLOGY
- Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: Additional analyses from the phase III RESORCE trial
- (2018) Richard S. Finn et al. JOURNAL OF HEPATOLOGY
- The role of molecular enrichment on future therapies in hepatocellular carcinoma
- (2018) Jean-Charles Nault et al. JOURNAL OF HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Hepatocellular carcinoma
- (2018) Alejandro Forner et al. LANCET
- Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
- (2018) Andrew X Zhu et al. LANCET ONCOLOGY
- Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study
- (2018) Lorenza Rimassa et al. LANCET ONCOLOGY
- Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
- (2018) Ghassan K. Abou-Alfa et al. NEW ENGLAND JOURNAL OF MEDICINE
- The EpCAM overexpression is associated with clinicopathological significance and prognosis in hepatocellular carcinoma patients: A systematic review and meta-analysis
- (2018) Linhua Zhou et al. International Journal of Surgery
- The immune contexture of hepatocellular carcinoma predicts clinical outcome
- (2018) Friedrich Foerster et al. Scientific Reports
- Alpha-Fetoprotein and Hepatocellular Carcinoma Immunity
- (2018) Xiaoping Wang et al. Canadian Journal of Gastroenterology and Hepatology
- Lenvatinib May Drastically Change the Treatment Landscape of Hepatocellular Carcinoma
- (2018) Masatoshi Kudo Liver Cancer
- Novel biomarkers in hepatocellular carcinoma
- (2018) Felice De Stefano et al. DIGESTIVE AND LIVER DISEASE
- Molecular therapies and precision medicine for hepatocellular carcinoma
- (2018) Josep M. Llovet et al. Nature Reviews Clinical Oncology
- Ten years of sorafenib in hepatocellular carcinoma: Are there any predictive and/or prognostic markers?
- (2018) Giorgia Marisi et al. WORLD JOURNAL OF GASTROENTEROLOGY
- The Role of Angiogenesis in Hepatocellular Carcinoma
- (2018) Michael A. Morse et al. CLINICAL CANCER RESEARCH
- Proteoglycans Are Attractive Biomarkers and Therapeutic Targets in Hepatocellular Carcinoma
- (2018) Yasuo Tanaka et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Comparative study of post-transplant outcomes in hepatocellular carcinoma patients treated with chemoembolization or radioembolization
- (2017) Ahmed Gabr et al. EUROPEAN JOURNAL OF RADIOLOGY
- Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features
- (2017) Daniela Sia et al. GASTROENTEROLOGY
- AASLD guidelines for the treatment of hepatocellular carcinoma
- (2017) Julie K. Heimbach et al. HEPATOLOGY
- Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
- (2017) Masao Omata et al. Hepatology International
- Structural basis for alpha fetoprotein-mediated inhibition of caspase-3 activity in hepatocellular carcinoma cells
- (2017) Bo Lin et al. INTERNATIONAL JOURNAL OF CANCER
- Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies
- (2017) Jordi Bruix et al. JOURNAL OF HEPATOLOGY
- Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification
- (2017) Julien Calderaro et al. JOURNAL OF HEPATOLOGY
- Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC
- (2017) Andrea Notarpaolo et al. JOURNAL OF HEPATOLOGY
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- A Novel Prognostic Index in Patients With Hepatocellular Cancer Waiting for Liver Transplantation
- (2016) Quirino Lai et al. ANNALS OF SURGERY
- Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients
- (2016) Sarah Berhane et al. Clinical Gastroenterology and Hepatology
- Advanced Hepatocellular Cancer: the Current State of Future Research
- (2016) Louise C. Connell et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- The extended Toronto criteria for liver transplantation in patients with hepatocellular carcinoma: A prospective validation study
- (2016) Gonzalo Sapisochin et al. HEPATOLOGY
- Alpha-fetoprotein and 18F-FDG positron emission tomography predict tumor recurrence better than Milan criteria in living donor liver transplantation
- (2016) Geun Hong et al. JOURNAL OF HEPATOLOGY
- Liver transplantation for hepatocellular carcinoma: evaluation of the alpha-fetoprotein model in a multicenter cohort from Latin America
- (2016) Federico Piñero et al. LIVER INTERNATIONAL
- The Prognostic Value of Alpha-Fetoprotein Response for Advanced-Stage Hepatocellular Carcinoma Treated with Sorafenib Combined with Transarterial Chemoembolization
- (2016) Lei Liu et al. Scientific Reports
- Total tumor volume and alpha-fetoprotein for selection of transplant candidates with hepatocellular carcinoma: A prospective validation
- (2015) Christian Toso et al. HEPATOLOGY
- Prediction of risk for hepatocellular carcinoma by response of serum α-fetoprotein to entecavir therapy
- (2015) Sung Wook Yang et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Applicability of BALAD score in prognostication of hepatitis B-related hepatocellular carcinoma
- (2015) Stephen L Chan et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial
- (2015) Andrew X Zhu et al. LANCET ONCOLOGY
- Development of Hong Kong Liver Cancer Staging System With Treatment Stratification for Patients With Hepatocellular Carcinoma
- (2014) Thomas Yau et al. GASTROENTEROLOGY
- A New Laboratory-Based Algorithm to Predict Development of Hepatocellular Carcinoma in Patients With Hepatitis C and Cirrhosis
- (2014) Hashem B. El-Serag et al. GASTROENTEROLOGY
- Oral antiviral therapy improves the diagnostic accuracy of alpha-fetoprotein levels in patients with chronic hepatitis B
- (2014) Jae-Jun Shim et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Silencing Alpha-Fetoprotein Inhibits VEGF and MMP-2/9 Production in Human Hepatocellular Carcinoma Cell
- (2014) Wenbo Meng et al. PLoS One
- A Peculiar Mutation Spectrum Emerging from Young Peruvian Patients with Hepatocellular Carcinoma
- (2014) Agnès Marchio et al. PLoS One
- Human and Mouse VEGFA-Amplified Hepatocellular Carcinomas Are Highly Sensitive to Sorafenib Treatment
- (2014) E. Horwitz et al. Cancer Discovery
- JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan
- (2014) Masatoshi Kudo et al. Liver Cancer
- Are Biomarkers Still Helpful in Hepatocellular Carcinoma?
- (2013) Rolf Lamerz DIGESTION
- On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir
- (2013) Grace L.H. Wong et al. HEPATOLOGY
- A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list
- (2013) Alessandro Vitale et al. JOURNAL OF HEPATOLOGY
- Serglycin (SRGN) overexpression predicts poor prognosis in hepatocellular carcinoma patients
- (2013) Lu He et al. MEDICAL ONCOLOGY
- Radiofrequency Ablation of Hepatocellular Carcinoma as First-Line Treatment: Long-term Results and Prognostic Factors in 162 Patients with Cirrhosis
- (2013) Dong Ho Lee et al. RADIOLOGY
- Alpha-fetoprotein: a renaissance
- (2013) A. A. Terentiev et al. TUMOR BIOLOGY
- Effectiveness of Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis
- (2012) A. G. Singal et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Plasma Biomarkers as Predictors of Outcome in Patients with Advanced Hepatocellular Carcinoma
- (2012) J. M. Llovet et al. CLINICAL CANCER RESEARCH
- Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan Criteria
- (2012) Christophe Duvoux et al. GASTROENTEROLOGY
- FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma
- (2012) Tokuzo Arao et al. HEPATOLOGY
- Usefulness of alpha-fetoprotein response in patients treated with sorafenib for advanced hepatocellular carcinoma
- (2012) Nicola Personeni et al. JOURNAL OF HEPATOLOGY
- Epidemiology and Surveillance of Hepatocellular Carcinoma
- (2012) Do Young Kim et al. Liver Cancer
- Frequency of Elevated Hepatocellular Carcinoma (HCC) Biomarkers in Patients With Advanced Hepatitis C
- (2011) Richard K Sterling et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Combination of biological and morphological parameters for the selection of patients with hepatocellular carcinoma waiting for liver transplantation
- (2011) Quirino Lai et al. CLINICAL TRANSPLANTATION
- Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Guidelines Proposed by the Japan Society of Hepatology (JSH) 2010 Updated Version
- (2011) Masatoshi Kudo et al. DIGESTIVE DISEASES
- The impact of waiting list alpha-fetoprotein changes on the outcome of liver transplant for hepatocellular carcinoma
- (2011) Shaheed Merani et al. JOURNAL OF HEPATOLOGY
- Superselective transarterial chemoembolization for hepatocellular carcinoma. Validation of treatment algorithm proposed by Japanese guidelines
- (2011) Kenichi Takayasu et al. JOURNAL OF HEPATOLOGY
- HCC and angiogenesis: possible targets and future directions
- (2011) Andrew X. Zhu et al. Nature Reviews Clinical Oncology
- Zhx2 and Zbtb20: Novel regulators of postnatal alpha-fetoprotein repression and their potential role in gene reactivation during liver cancer
- (2011) Martha L. Peterson et al. SEMINARS IN CANCER BIOLOGY
- MicroRNA122 is a key regulator of α-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma
- (2011) Kentaro Kojima et al. Nature Communications
- Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma
- (2010) Yu-Yun Shao et al. CANCER
- National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Liver, Bladder, Cervical, and Gastric Cancers
- (2010) C. M. Sturgeon et al. CLINICAL CHEMISTRY
- Favorable α-fetoprotein decrease as a prognostic surrogate in patients with hepatocellular carcinoma after radiofrequency ablation
- (2010) Ming-Chao Tsai et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- A new prognostic model for hepatocellular carcinoma based on total tumor volume: The Taipei Integrated Scoring system
- (2010) Chia-Yang Hsu et al. JOURNAL OF HEPATOLOGY
- Angiogenesis and clinicopathologic characteristics in different hepatocellular carcinoma subtypes defined by EpCAM and α-fetoprotein expression status
- (2010) Yun-feng Shan et al. MEDICAL ONCOLOGY
- Progression of Alphafetoprotein Before Liver Transplantation for Hepatocellular Carcinoma in Cirrhotic Patients: A Critical Factor
- (2009) E. Vibert et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis
- (2009) S J Schoenleber et al. BRITISH JOURNAL OF CANCER
- Integrative Transcriptome Analysis Reveals Common Molecular Subclasses of Human Hepatocellular Carcinoma
- (2009) Y. Hoshida et al. CANCER RESEARCH
- α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma
- (2009) Jorge A. Marrero et al. GASTROENTEROLOGY
- Des-γ-Carboxy Prothrombin and α-Fetoprotein as Biomarkers for the Early Detection of Hepatocellular Carcinoma
- (2009) Anna S. Lok et al. GASTROENTEROLOGY
- Radiofrequency ablation of hepatocellular carcinoma: Long-term results and prognostic factors in 235 Western patients with cirrhosis
- (2009) Gisèle N'Kontchou et al. HEPATOLOGY
- A new staging system is more discriminant than conventional staging systems for unresectable hepatocellular carcinoma
- (2009) Bai-Hong Zhang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- ZHX2 is a repressor of α-fetoprotein expression in human hepatoma cell lines
- (2009) H. Shen et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Alpha-Fetoprotein Response After Locoregional Therapy for Hepatocellular Carcinoma: Oncologic Marker of Radiologic Response, Progression, and Survival
- (2009) Ahsun Riaz et al. JOURNAL OF CLINICAL ONCOLOGY
- Liver Transplantation for Hepatocellular Carcinoma: Hangzhou Experiences
- (2009) Shu-Sen Zheng et al. TRANSPLANTATION
- Liver Transplantation for Hepatocellular Carcinoma: Results of Down-Staging in Patients Initially Outside the Milan Selection Criteria
- (2008) M. Ravaioli et al. AMERICAN JOURNAL OF TRANSPLANTATION
- A new prognostic score system in patients with advanced hepatocellular carcinoma not amendable to locoregional therapy
- (2008) Thomas Yau et al. CANCER
- EpCAM and -Fetoprotein Expression Defines Novel Prognostic Subtypes of Hepatocellular Carcinoma
- (2008) T. Yamashita et al. CANCER RESEARCH
- New Utility of an Old Marker: Serial α-Fetoprotein Measurement in Predicting Radiologic Response and Survival of Patients With Hepatocellular Carcinoma Undergoing Systemic Chemotherapy
- (2008) Stephen L. Chan et al. JOURNAL OF CLINICAL ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started